Clinical Trial Update: Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase I study of low-dose Whole Abdominal Radiation Therapy (WART) in combination with weekly paclitaxel for platinum-res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• WART (Whole Abdominal Radiation Therapy)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Ovarian Cancer | Phase 1 | Status: UNKNOWN